Uncategorised - European Medical Journal

Going for gold in gynaecological cancers

The pharmaceutical industry is being urged to take action to bridge the access gap for women with gynaecological cancers, but what steps are needed to change the game?

Low Risk of Bacteraemia in Children with Sickle Cell Disease

Breaking research suggests that bacteraemia is uncommon among children and young adults with sickle cell disease.

Optical Coherence Tomography Improves Recurrent Basal Cell Carcinoma Detection

Combining CDE with OCT significantly improves detection of residual and recurrent superficial basal cell carcinoma…

Infographic: The Menopause Symptoms and Breaking the Stigma

Exploring the menopause, this infographic outlines the main symptoms experienced across Europe, particularly focusing on vasomotor…

Does Diabetes Increase Breast Cancer Risk?

Breast cancer is the most common type of cancer amongst females, and its risk could be influenced by metabolic abnormalities…

Progressive Facial Hemiatrophy (Parry–Romberg Syndrome) Treated with Hyaluronic Acid Fillers

Parry–Romberg syndrome (PRS) is a rare neurocutaneous condition that can affect the skin, subcutaneous fat, muscle, and bone on one side…

Is High Caffeine Intake Linked to Greater Prevalence of Severe Headaches and Migraines?

An higher daily intake of dietary caffeine is associated with an increased prevalence of severe headache or migraine in adults…

Getting to the Roots of the Problem: A Discussion on Alopecia and Patient Compliance

Michela Starace joins Jonathan to discuss hair loss and its impacts on patients as well as patient compliance

Examining Coping Strategies and Their Impact on the Wellbeing of Patients with Parkinson’s

A study identifies the predictors of coping strategies for patients with PD, and evaluated their impact on health-related quality of life…

ECTRIMS 2022 Symposium: The Burden of Cognitive Impairment in MS

The Burden of Cognitive Impairment in MS, ECTRIMS 2022 BMS-sponsored Symposium, highlights the importance of early awareness of cognitive impairment (CI), the impact to activities of daily living in patients with MS, the association of CI with MRI alterations and brain atrophy. 𝗙𝗼𝗿 𝗛𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲 𝗣𝗿𝗼𝗳𝗲𝘀𝘀𝗶𝗼𝗻𝗮𝗹𝘀 𝗼𝗻𝗹𝘆. 𝗧𝗵𝗶𝘀 𝘀𝘆𝗺𝗽𝗼𝘀𝗶𝘂𝗺 𝘄𝗮𝘀 𝗼𝗿𝗴𝗮𝗻𝗶𝘀𝗲𝗱 𝗮𝗻𝗱 𝗳𝘂𝗻𝗱𝗲𝗱 𝗯𝘆 𝗕𝗿𝗶𝘀𝘁𝗼𝗹 𝗠𝘆𝗲𝗿𝘀 𝗦𝗾𝘂𝗶𝗯𝗯. 𝗕𝗠𝗦 𝗺𝗲𝗱𝗶𝗰𝗶𝗻𝗲𝘀 𝗮𝗻𝗱/𝗼𝗿 𝗽𝗿𝗼𝗱𝘂𝗰𝘁 𝗶𝗻𝗳𝗼𝗿𝗺𝗮𝘁𝗶𝗼𝗻 𝗺𝗮𝘆 𝗯𝗲 𝗱𝗶𝘀𝗰𝘂𝘀𝘀𝗲𝗱. 𝗜𝗠𝗠-𝗚𝗕-𝟮𝟯𝟬𝟬𝟯𝟵𝟬 𝗦𝗲𝗽𝘁 𝟮𝟯.